Print

Print


Several studies have shown that pharmacological and cognitive treatments for 
Alzheimers's disease improve cognitive function for short periods, but fewer 
studies have evaluated the efficacy of those treatments for longer (2-year) 
periods. An initial sample of 68 subjects with mild Alzheimer's disease 
underwent clinical and cognitive evaluation. After evaluation, subjects were 
assigned to four different groups and participated in a 2-year follow-up study. 
Group 1 (n = 14) received combined drug and cognitive stimulation, group 2 (n 
= 20) received only drug treatment, group 3 (n = 14) received only cognitive 
stimulation, and group 4 (n = 30) received no treatment at all. Results 
confirmed previous investigation, cognitive and combined stimulation improved 
patients' performance throughout the 1st year; however, all groups 
deteriorated gradually throughout the 2nd year of treatment. According to this 
evidence, it can be concluded that we cannot stop cognitive deterioration 
after 2 years of treatment, although deterioration is greater and its progress 
faster in patients not receiving any treatment at all.

http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000095600

maryse

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn